Showing posts with label trade name Daklinza) is a drug for the treatment of hepatitis. Show all posts
Showing posts with label trade name Daklinza) is a drug for the treatment of hepatitis. Show all posts
Monday, April 11, 2016

EC approves expanded use of Daklinza (daclatasvir) for patients with chronic HCV and HIV co-infection

›
Daclatasvir  formerly  BMS-790052 , trade name  Daklinza ) is a drug for the treatment of hepatitis C (HCV). It was developed by Bri...